Phase
Condition
Uterine Fibroids
Leiomyomas
Sarcoma (Pediatric)
Treatment
N/AClinical Study ID
Ages 18-70 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Inclusion criteria were as follows: women who had myoma-related symptoms such asmenorrhagia, pelvic pressure/pain, or infertility; women who were not pregnant at the timeof presentation (i.e., negative for urine pregnancy test or last menstrual period withinthe last 4 weeks); and women who were appropriated medical status for laparoscopic surgery (American Society of Anesthesiologists Physical Status classification 1 or 2).
Exclusion
Exclusion Criteria: Exclusion criteria included any other uterine or adnexal abnormalities (e.g., abnormalendometrial thickness, and suspected ovarian or uterine malignancy), any sign of genitalinfection, presence of submucosal or pedunculated myoma as a dominant myoma, treatment ofgonadotropin-releasing hormone (GnRH) agonist 2 months before surgery, or an inability tounderstand and provide written informed consent.
Study Design
Study Description
Connect with a study center
CHA Gangnam Medical Center
Seoul,
Korea, Republic ofSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.